NEC’s artificial intelligence (AI) supports doctors to determine if colorectal lesions are potentially neoplastic
NEC’s artificial intelligence (AI) supports doctors to determine if colorectal lesions are potentially neoplastic

TOKYO, Jul 14, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (NEC; TSE: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new technology, called “Cx20,” while seeking to assist in the early detection of colorectal lesions. Cx20 has... » read more

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan
NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

TOKYO, Jan 12, 2021 – (JCN Newswire) – NEC Corporation (TSE: 6701) has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe. This software connects with existing endoscopy equipment as part of using... » read more